CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants
Andrew D Redd, Alessandra Nardin, Hassen Kared, Evan M Bloch, View ORCID ProfileAndrew Pekosz, Oliver Laeyendecker, Brian Abel, Michael Fehlings, Thomas C Quinn, Aaron AR Tobian
doi: https://doi.org/10.1101/2021.02.11.21251585
Andrew D Redd
1Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
2Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Alessandra Nardin
3ImmunoScape Pte Ltd, Singapore
Hassen Kared
3ImmunoScape Pte Ltd, Singapore
Evan M Bloch
4Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Andrew Pekosz
5Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Oliver Laeyendecker
1Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
2Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Brian Abel
3ImmunoScape Pte Ltd, Singapore
Michael Fehlings
3ImmunoScape Pte Ltd, Singapore
Thomas C Quinn
1Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
2Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Aaron AR Tobian
4Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The data used in this analysis is available in a previous publication "SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals"
Posted February 12, 2021.
CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants
Andrew D Redd, Alessandra Nardin, Hassen Kared, Evan M Bloch, Andrew Pekosz, Oliver Laeyendecker, Brian Abel, Michael Fehlings, Thomas C Quinn, Aaron AR Tobian
medRxiv 2021.02.11.21251585; doi: https://doi.org/10.1101/2021.02.11.21251585
CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants
Andrew D Redd, Alessandra Nardin, Hassen Kared, Evan M Bloch, Andrew Pekosz, Oliver Laeyendecker, Brian Abel, Michael Fehlings, Thomas C Quinn, Aaron AR Tobian
medRxiv 2021.02.11.21251585; doi: https://doi.org/10.1101/2021.02.11.21251585
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (669)
- Anesthesia (181)
- Cardiovascular Medicine (2651)
- Dermatology (224)
- Emergency Medicine (400)
- Epidemiology (12236)
- Forensic Medicine (10)
- Gastroenterology (761)
- Genetic and Genomic Medicine (4110)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2663)
- Health Policy (1005)
- Hematology (364)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (439)
- Neurology (3890)
- Nursing (210)
- Nutrition (578)
- Oncology (2037)
- Ophthalmology (585)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6537)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (410)
- Sports Medicine (343)
- Surgery (451)
- Toxicology (53)
- Transplantation (185)
- Urology (166)